GRP
CTKB icon

Global Retirement Partners’s Cytek Biosciences CTKB Stock Holding History

Global Retirement Partners’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13K Buy
+932
New +$3.98K ﹤0.01% 3754

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Global Retirement Partners's CTKB Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 932 shares worth $4.13K. The stake represents ﹤0.01% of the portfolio and ranks #3754 among its holdings.

155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Global Retirement Partners held 932 shares of Cytek Biosciences worth $4.13K as of Q2 2026.
  • Cytek Biosciences was a new Global Retirement Partners position in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3754 holding.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.